Evidence map›Paper›PMID 21652700›Full record

ArticleThe Journal of biological chemistry2011

Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses.

Baibaswata Nayak, Vinay K Kondeti, Ping Xie, Sun Lin, Navin Viswakarma, Kirtee Raparia, Yashpal S Kanwar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes.The Journal of clinical endocrinology and metabolism · 2021
    Trial
  2. Article
  3. Review
  4. Review
  5. Inositol in Disease and Development: Roles of Catabolism viaInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. American journal of physiology. Renal physiology · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Diabetes · 2020
    Article
  16. Inositols and metabolic disorders: From farm to bedside.Journal of traditional and complementary medicine · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Baibaswata NayakDepartment of Pathology, Northwestern University, Chicago, Illinois 60611, USA.
Vinay K Kondeti
Ping Xie
Sun Lin
Navin Viswakarma
Kirtee Raparia
Yashpal S Kanwar
Northwestern University · USSecond Xiangya Hospital of Central South University · CN

Funding

Pathogenesis of Diabetic NephropathyR01DK060635 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUAGGIN, SUSAN E. · 2002 to 2023
$6.6M
NIDDK NIH HHS DK60635NIDDK NIH HHS R01 DK060635
6 · The paper itself

Abstract

Renal-specific oxidoreductase/myo-inositol oxygenase (RSOR/MIOX) catabolizes myo-inositol and is implicated in the pathogenesis of diabetic nephropathy. How high glucose (HG) ambience up-regulates its expression and enzyme activity was investigated. MIOX up-regulation was associated with an increase in enzyme activity, which was reduced to basal levels with phosphatase treatment. Using phosphothreonine, protein kinase A (PKA), and PKC substrate antibodies, analyses of kidney lysates of diabetic animals and LLC-PK1/HK-2 cells subjected to HG ambience indicated MIOX to be a phosphoprotein. Kinase phosphorylated recombinant RSOR/MIOX proteins had increased activity confined to exons 2-5. Mutants with substituted phosphorylation sites had a minimal increase in activity. Treatment of cells with PKC, PKA, and PDK1 kinase activators increased activity, whereas inhibitors reduced it. Inhibitors also reduced the phosphorylation and activity of MIOX induced by HG. Besides HG, exposure of cells to oxidants H(2)O(2) and methylglyoxal up-regulated MIOX expression and its phosphorylation and activity, whereas antioxidants N-acetylcysteine, β-naphthoflavone, and tertiary butyl hydroquinone reduced MIOX expression. Treatment with HG or oxidants or overexpression of MIOX induced nuclear translocation of redox-sensitive transcription factor Nrf2, which binds to antioxidant response elements of various promoters. Promoter analyses revealed an increase in luciferase activity with HG and oxidants. Analyses of antioxidant response elements and carbohydrate response elements revealed an accentuation of DNA-protein interactions with oxidants and under HG ambience. ChIP-PCR and immunofluorescence studies revealed nuclear translocation of carbohydrate response element-binding protein. These findings suggest that phosphorylation of RSOR/MIOX enhances its activity, which is augmented by HG via transcriptional/translational events that are also modulated by diabetes-related pathobiological stresses.

Indexed as

Protein Processing, Post-TranslationalStress, PhysiologicalTranscription, GeneticAnimalsBase SequenceBlotting, WesternCell LineChromatin ImmunoprecipitationDiabetes Mellitus, ExperimentalDNA PrimersElectrophoresis, Polyacrylamide GelElectrophoretic Mobility Shift AssayGlucoseInositol OxygenaseKidney Tubules, ProximalMiceDNA PrimersGlucoseInositol Oxygenase

Identifiers

PMID21652700
PMCPMC3149351
OpenAlexW1975252193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.